¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gradient induced phase shift effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • gradient echo technique
    ±â¿ï±â¿¡ÄÚ¹ý
  • gradient limiting reabsorption
    ³óµµ°æ»çÁ¦ÇÑÀçÈí¼ö
  • gradient magnetic field
    ±â¿ï±âÀÚ±âÀå, °æ»çÀÚ±âÀå
  • gradient method
    °è´Ü°Ë»ç¹ý
  • gradient moment
    ±â¿ï±â¸ð¸àÆ®
  • gradient moment nulling
    ±â¿ï±â¸ð¸àÆ®¹«È¿È­
  • gradient motion rephasing
    ±â¿ï±â¿îµ¿ÀçÀ§»óÈ­
  • gradient refocused acquisition
    ±â¿ï±âÀçÃÊÁ¡È¹µæ
  • gradient refocused imaging
    ±â¿ï±âÀçÃÊÁ¡¿µ»ó
  • gradient shielding
    °æ»çÂ÷Æó
  • gradient slope
    °æ»ç±â¿ï±â
  • ion gradient
    À̿±â¿ï±â, À̿°æ»ç
  • imaging gradient
    ¿µ»ó±â¿ï±â
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • diffusion gradient pulse
    È®»ê°æ»ç¸Æ¹Ú, È®»ê°æ»ç¸Æ¹Ú
  • electric potential gradient
    ÀüÀ§±â¿ï±â
  • electrical gradient
    Àü±â±â¿ï±â
  • electrochemical gradient
    Àü±âÈ­Çбâ¿ï±â
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§±â¿ï±â
  • epidemiological gradient
    ¿ªÇÐÀû±¸¹è, ¿ªÇÐÀû±â¿ï±â
  • gradient echo
    ±â¿ï±â¿¡ÄÚ
  • pulsed gradient spin echo
    ÆÞ½º±â¿ï±â½ºÇÉ¿¡ÄÚ
  • fast gradient recalled echo method
    °í¼Ó±â¿ï±âȸº¹¿¡ÄÚ¹ý
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ±â¿ï±âȸº¹¿¬¼â
  • flow compensation gradient technique
    È帧º¸»ó±â¿ï±â±â¹ý
  • flow sensitive gradient echo sequence
    È帧¹Î°¨±â¿ï±â¸Þ¾Æ¸®¿¬¼â
  • frequency encoding gradient
    Á֯ļöºÎȣȭ±â¿ï±â
  • gradient magnetic field
    ±â¿ï±âÀÚ±âÀå, °æ»çÀÚ±âÀå
  • gradient
    ±â¿ï±â, °æ»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Gibbs effect
    ±é½º È¿°ú
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
  • Purkinje effect
    Ǫ¸£Å°´Ï¿¡È¿°ú
  • RF antennae effect
    °íÁÖÆÄ ¾ÈÅ׳ª È¿°ú
  • Stiles-Crawford effect
    ½ºÅ¸ÀϽº-Å©·ÎÆ÷µåÈ¿°ú
  • T1 shortening effect
    T1 ´ÜÃà È¿°ú
  • T2 shortening effect
    T2 ´ÜÃà È¿°ú
  • Tyndall effect
    ƾ´ÞÈ¿°ú
  • additive effect
    ºÎ°¡È¿°ú
  • additive effect
    »ó°¡È¿°ú (ßÓÊ¥üùÍý)
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • air barrier effect
    °ø±â¸·È¿°ú(ÍöѨدüùÍý).
  • air gap effect
    °ø±â °£°Ý È¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • drug-induced systemic lupus erythematosus
    ¾à¹°À¯¹ß Àü½Å¼ºÈ«¹Ý¼º ·çǪ½º
  • drug-induced vasculitis
    ¾à¹° À¯¹ß Ç÷°ü¿°
  • electric potential gradient
    ÀüÀ§(îïêÍ)±â¿ï±â.
  • electrical gradient
    Àü±â±¸¹è(ÎþÛÕ)
  • electrochemical gradient
    Àü±âÈ­ÇÐÀû ±¸¹è(Ï£ÛÕ)(°æ»ç(ÌËÞØ))
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§(ï³Ñ¨ûùùÊï³êÈ)±â¿ï±â.
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§±â¿ï±â.
  • electrochemicaql potential gradient
    Àü±âÈ­ÇÐÀûÀüÀ§±¸¹è(°æ»ç)
  • epidemiological gradient
    ¿ªÇÐÀû ±¸¹è.
  • equilibrium density gradient centrifugation
    ÆòÇü¹Ðµµ±¸¹è¿ø½É¹ý(¡­ÚËöôÎþÛÕêÀãýÛö).
  • exercise-induced anaphylaxis
    ¿îµ¿ À¯µµ¼º À̳ªÇʶô½Ã½º
  • exercise-induced hematuria
    ¿îµ¿À¯¹ßÇ÷´¢
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ¼º °íÁö¹æÇ÷Áõ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • preinductive phase
    ÀüÀ¯µµ±â(îñë¯ÓôÑ¢)
  • productive phase
    »ý»ê±â(ßæß§Ñ¢)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • regeneration phase
    Àç»ý±â(î¢ßæÑ¢)
  • reversed phase chromatography
    ¿ª»ó(æ½ßÓ) Å©·Î¸¶Åä±×·¡ÇÇ
  • solid phase synthesis
    °í»óÇÕ¼º(ͳßÒùêà÷)
  • stationary phase
    "Á¤Áö»ó(ïÎò­ßÓ), Á¤Áö±â(ïÎò­Ñ¢)"
  • transient phase
    °úµµ»ó(ΦԤßÒ)
  • vapor phase chromatography
    Áõ±â»ó(ñúѨßÓ) Å©·Î¸¶Åä±×·¡ÇÇ
  • anomeric effect
    ¾Æ³ë¸Ó¿µÇâ(ç¯úÂ)
  • asymmetry effect
    ºÎÀçÈ¿°ú(Üôî²üùÍý)
  • Blinks effect
    ºí¸°Å©½º È¿°ú(üùÍý) (ÔÒ) chromatic transient
  • Bohr effect
    º¸¾î È¿°ú(üùÍý)
  • charge effect
    ÀüÇÏÈ¿°ú(ï³ùÃüùÍý)
  • chronotropic effect
    º¯½Ã¼ºÈ¿°ú(ܨãÁàõüùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • portal phase
    ¹®¸Æ±â
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • resting phase
    È޽ıâ
  • spin phase
    ½ºÇÉÀ§»ó
  • test phase
    ½ÃÇè±â
  • venous phase
    Á¤¸Æ»ó, Á¤¸Æ±â
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • B1 field gradient
    ȸÀüÀÚÀå°æ»ç
  • background gradient
    ¹è°æ°æ»ç
  • bipolar gradient
    ¾ç±Ø°æ»ç
  • bipolar velocity encoding gradient
    ¾ç±Ø¼ÓµµºÎȣȭ°æ»ç
  • constant field gradient spin echo method
    °íÁ¤°æ»çÀ彺ÇÉ¿¡ÄÚ¹ý
  • constant gradient
    °íÁ¤°æ»ç
  • diffusion gradient pulse
    È®»ê°æ»çÆÞ½º
  • fast gradient recalled echo method
    °í¼Ó°æ»çȸº¹¿¡ÄÚ±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
GGE generalized glandular enlargement; gradient gel electrophoresis
GMN gradient moment nulling
GMR gallops, murmurs, rubs; gradient motion rephasing
grad gradient; gradually; graduate
GRASS gradient recalled acquisition in a steady state
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
SAAG Serum-Ascites Albumin Gradient
SDG Sucrose density gradient
TGGE Temperature Gradient Gel Electrophoresis
TTGE Temporal Temperature Gradient Gel Electrophoresis
EFG electric field gradient
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lysogenic phase
    ¿ë¿ø±â
  • maximal ejection phase
    ÃÖ´ë ±¸Ãâ±â
  • mitotic phase
    À¯»ç ºÐ¿­±â
  • phase 1 study
    ÀÓ»ó Á¦1»ó ½ÃÇè
  • phase artifact
    À§»ó Àΰø¹°
  • phase boundary
    »ó°è
  • phase coherence
    À§»ó °áÁý
  • phase contrast
    À§»ó ´ëÁ¶
  • phase curve
    À§»ó °î¼±
  • phase display
    À§»ó Ç¥½Ã
  • phase encoding
    À§»ó ºÎȣȭ
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
  • phase frequency swap
    À§»ó Á֯ļö ±³È¯
  • phase II treatment
    Á¦2´Ü°è Ä¡·á
  • phase mismapping
    À§»ó ¿ÀÁöµµ ÀÛ¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
exercise-induced amenorrhoea The temporary cessation of menstrual function due to strenuous, daily exercise, as in jogging; increased endorphins inhibiting hypothalamic function.
(05 Mar 2000)
familial fat-induced hyperlipaemia Hyperlipoproteinaemia characterised by the presence of large amounts of chylomicrons and triglycerides in the plasma when the patient has a normal diet, and their disappearance on a fat-free diet; low alpha-and beta-lipoproteins on a normal diet, with increase on fat-free diet; decreased plasma postheparin lipolytic activity; and low tissue lipoprotein lipase activity. It is accompanied by bouts of abdominal pain, hepatosplenomegaly, pancreatitis, and eruptive xanthomas; autosomal recessive inheritance.
See: familial lipoprotein lipase inhibitor.
Synonym: Burger-Grutz syndrome, familial fat-induced hyperlipaemia, familial hyperchylomicronaemia, familial hypertriglyceridemia, idiopathic hyperlipaemia.
(05 Mar 2000)
lens-induced uveitis Intraocular inflammation occurring after extracapsular cataract extraction;probably an immune reaction to the patient's liberated lenticular proteins.
Synonym: lens-induced uveitis.
(05 Mar 2000)
leucine-induced hypoglycaemia Rare cause of hypoglycaemia occurring following ingestion of leucine. Seen especially in infants.
(05 Mar 2000)
ligand induced endocytosis The formation of coated pits and then coated vesicles as a consequence of the interaction of ligand with receptors, which then interact with clathrin and associated proteins (coatomers) on the cytoplasmic face of the plasma membrane and come together to form a pit. Not all coated vesicle uptake of receptors requires receptor occupancy.
(18 Nov 1997)
abscopal effect A reaction produced following irradiation but occurring outside the zone of actual radiation absorption.
(05 Mar 2000)
additive effect <biochemistry, chemistry> An additive effect is the overall biological effect two chemicals acting together and which is the simple sum of the effects of the chemicals acting independently.
Compare: antagonism.
(15 Jan 1998)
adverse effect This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical.
(09 Oct 1997)
Anrep effect A small transient positive inotropic effect of abrupt increases of systolic aortic and left ventricular pressures related to recovery from transient subendocardial ischemia (e.g., cold pressor test).
(05 Mar 2000)
antagonistic effect This is the consequence of one chemical (or group of chemicals) counteracting the effects of another chemical, the opposing chemicals cancel out each other's effects.
(09 Oct 1997)
Arias-Stella effect Focal, unusual, decidual changes in endometrial epithelium, consisting of intraluminal budding, and nuclear enlargement and hyperchromatism with cytoplasmic swelling and vacuolation; may be associated with ectopic or uterine pregnancy.
Synonym: Arias-Stella effect, Arias-Stella reaction.
(05 Mar 2000)
Auger effect <physics> Transition of an electron in an atom from a discrete electronic level to an ionised continuous level with the same energy.
Synonym: autoionisation.
(13 Jan 1998)
autokinetic effect In psychology, the apparent drifting about of a small, fixed, spot of light which is being observed in a dark room.
(05 Mar 2000)
Bernoulli effect <physics> The decrease in fluid pressure that occurs in converting potential to kinetic energy when motion of the fluid is accelerated, in accordance with Bernoulli's law.
Applied in water aspirators, atomisers, and humidifiers in which a gas is accelerated across the end of a narrow, fluid-filled orifice.
(05 Mar 2000)
Bohr effect <physiology> Decrease in oxygen affinity of haemoglobin when pH decreases or concentration of carbon dioxide increases.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á